top of page



2022 Patient and Care Partner Conference

Join us at our in-person two-day conference in St. Louis, Missouri on July 22 and 23! Register by June 30th for the early bird rate of $25.


Jul 22, 9:00 AM CDT – Jul 23, 8:00 PM CDT

The Westin St. Louis, 811 Spruce St, St. Louis, MO 63102, USA

2022 Patient Conference Logo (600 × 312 px) (4).png

Patient Happy Hours

These Zoom meetings are a way to connect with VCP families around the world and share experiences.  There is no agenda or drink required.   


Because we have members all over the world, we offer two separate happy hours each month, typically on the second Wednesday and Saturday at 8:00 Eastern Time.

Copy of Cure VCP Disease Happy Hour.png

Million Dollar Bike Ride

Cure VCP Disease sponsored a team to ride in the 7th Annual Million Dollar Bike Ride on Saturday, June 13, 2020. In the past, this event was held in Philadelphia, Pennsylvania, but this year the ride was virtual with each rider biking in their own town, either individually or in a small group. The event is hosted by the Penn Medicine Orphan Disease Center (ODC) to raise money for rare disease.

Team Cure VCP Disease is one of 39 teams participating and rode over 700 miles to raise awareness for our rare disease. More Information>


VCP Scientific Focus Group

Scientists interested in investigating p97 / VCP are encouraged to join our VCP Scientific Focus Group which meets monthly. Leading international researchers from 20 top institutions discuss their current research and collaboration. Participation in this group is by invitation only. Contact us at for more information.

Copy of Copy of Copy of VCP Scientific Conference - Helix.png

Educational Webinars

Join us monthly as experts present  important topics to patients concerning current research, financial planning, and current therapies to help you learn more about VCP disease and how to manage it.  Registration is listed on our homepage and social media.

Standard of Care.png

FDA Listening Session

On May 5, 2020, Cure VCP Disease was granted a Patient Listening Session with leadership of the U.S. Food and Drug Administration (FDA).  During the meeting, the FDA listened to five patients' and caregivers' stories to better understand their experiences with VCP disease & IBMPFD. This was an important opportunity to bring attention to the burden and needs of the VCP disease community.  We appreciate the bravery and efforts of those patients and caregivers who shared their stories.


One of the comments made by an FDA representative was that she found the meeting "incredibly educational" and "brought to life a greater understanding of the disease."

The meeting was closed to the public and therefore a recording of the meeting is not available.  We do have a summary of the meeting.  More Information >

bottom of page